2013 – Biz News Today

Norwegian Cruise Line Announces Exercise of Underwriters’ Option to Purchase Additional Shares

On December 27, 2013

Business News

Norwegian Cruise Line Holdings Ltd. (Nasdaq:NCLH) (“Norwegian”) announced today thatRead More

FDA Accepts For Review ELIQUIS® (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE

On December 19, 2013

Business News

Original Source

Bristol-Myers Squibb Announces Dividend Increase

On December 19, 2013

Business News

Original Source

Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business

On December 19, 2013

Business News

Original Source

Bristol-Myers Squibb Foundation Awards $3.28 Million in Grants to Support Mental Health Needs of U.S. Military Service Members Returning from Afghanistan and Iraq

On December 17, 2013

Business News

Original Source

FDA Advisory Committee Recommends the Investigational SGLT2 Inhibitor Dapagliflozin for the Treatment of Type 2 Diabetes in Adults

On December 12, 2013

Business News

Original Source

FDA Advisory Committee Votes on Investigational Medicine Metreleptin

On December 11, 2013

Business News

Original Source

Bristol-Myers Squibb Names Thomas J. Lynch, Jr., M.D. to Board of Directors

On December 10, 2013

Business News

Original Source

Bristol-Myers Squibb Foundation Announces Two Grants to Fund Cancer Nursing Centers of Excellence in Russia and the Czech Republic

On December 10, 2013

Business News

Original Source

Norwegian Opens Summer and Year-Round 2015 Itineraries

On December 10, 2013

Business News

Norwegian Cruise Line today announced and opened for sale itsRead More

Four-Year Data from Phase 3 DASISION Trial Comparing Sprycel® (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Presented at Annual Meeting of the American Society of Hematology

On December 9, 2013

Business News

Original Source

Norwegian Cruise Line Announces Pricing of Secondary Public Offering by Principal Shareholders

On December 3, 2013

Business News

Norwegian Cruise Line Holdings Ltd. (Nasdaq:NCLH) (“Norwegian”) announced today theRead More

Norwegian Cruise Line Announces Launch of Secondary Public Offering By Principal Shareholders

On December 2, 2013

Business News

Norwegian Cruise Line Holdings Ltd. (Nasdaq: NCLH) (“Norwegian”) announced todayRead More

Xigduo™ (dapagliflozin and metformin hydrochloride) Receives Positive CHMP Opinion in the European Union for the Treatment of Type 2 Diabetes

On November 22, 2013

Business News

Original Source

NORWEGIAN GETAWAY BEGINS HER CONVEYANCE ALONG THE EMS RIVER

On November 15, 2013

Business News

Norwegian Getaway, Miami’s Ultimate Ship, departed MEYER WERFT in Papenburg,Read More

Bristol-Myers Squibb Foundation Marks World Diabetes Day with Four Grants Addressing Link Between Diabetes, Depression and Distress

On November 14, 2013

Business News

Original Source

Bristol-Myers Squibb Announces Changes in Senior Management Team

On November 13, 2013

Business News

Original Source

Typhoon Haiyan Relief

On November 12, 2013

Business News

Everyone at Norwegian Cruise Line is truly saddened to hearRead More

Norwegian Getaway Begins HerConveyance Along the Ems River

On November 4, 2013

Business News

Norwegian Getaway, Miami’s Ultimate Ship, departed MEYER WERFT in Papenburg,Read More

Bristol-Myers Squibb Submits First All-Oral, Interferon-Free and Ribavirin-Free Treatment Regimen for Regulatory Review in Japan for Patients with Chronic Hepatitis C Infection

On November 2, 2013

Business News

Original Source